Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|June 24, 2013
- June 2013
- Volume 17
- Issue 1
Multiple Factors Linked to Readmission After GI Surgery
Advertisement
Multiple factors may be responsible for patient readmissions 30 days following major gastrointestinal surgery, according to a recent study presented on May 19, 2013, at Digestive Disease Week. Steroid use before surgery, operative time, and place of discharge were all identified as risk factors. Researchers also found that patients who experience complications in the hospital are one-third more likely to be readmitted.
Articles in this issue
about 13 years ago
Pain Control: Using Nonprescription Analgesicsabout 13 years ago
US-Born Children Have More Asthma, Allergies Than Immigrant Peersabout 13 years ago
Finding Effective Relief for Constipationabout 13 years ago
Case Studies in Self-Careabout 13 years ago
Multivitamin/Multimineral Supplement Useabout 13 years ago
Acetaminophen Helps Death Fearsabout 13 years ago
2012-2013 The Medical Year in Reviewabout 13 years ago
Pharmacy Times: Leading the Wayabout 13 years ago
Activity Helps Hot Flashes & Night Sweatsabout 13 years ago
Weight Gain During Pregnancy Increases Laceration RiskAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
Radioligand Therapy Doesn’t Need to Be Risk-Free—It Needs to Be Worth It
3
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
4
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
5